Taconic Biosciences is improving its services to Alzheimer’s disease researchers — creating a ready-to-use stock of an important mouse model…
Articles by Magdalena Kegel
Axsome Therapeutics’ investigational drug AXS-05 was recently granted fast track designation by the U.S. Food and Drug Administration (FDA)…
The schizophrenia medication Rexulti (brexpiprazole) reduced agitation in patients with Alzheimer’s disease, newly released data from two Phase 3…
Sedatives increase the risk of pneumonia in people with Alzheimer’s disease, according to a recent study, acting as a reminder…
Cardiovascular risk factors in middle age contribute later in life to amyloid-beta plaque in the brain, according to a comprehensive study that…
The Alzheimer’s disease scientific community is changing its research focus from treatment to prevention, according to researchers from the…
Americans who want to assess their risk for late-onset Alzheimer’s disease may now order $199 genetic tests, now that the U.S.
So-called “SuperAgers” lose brain volume more slowly than their normally aging peers, protecting them from dementia, according to a new study…
Alzheimer’s disease and other neurological illnesses cost Americans about $789 billion in 2014 — a price tag that will go only…
Mice with Alzheimer’s who are unable to produce the protein Ephexin5 have no memory problems, despite having brains littered with…